Appendix A - Aetna

Systemic Lupus Erythematosus Members with severe active SLE for whom first- and second-line therapies have been unsuccessful, have become intolerable, or are contraindicated. Note: Standard first-line therapy of active SLE include non-steroidal anti-inflammatory drugs, followed by low-dose corticosteroids and antimalarial compounds. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download